Protective proteins reduce damage to blood vessels

May 21, 2014
Calcium phosphate crystals (needle-shaped, indicated by arrows) are being engulfed by a human vascular smooth muscle cell (SMC). Credit: Babraham Institute

Researchers have uncovered how proteins found in our blood can reduce damage caused to blood vessels as we age, and in conditions such as atherosclerosis and arthritis.

Calcification is a major risk factor for heart attack and stroke. Blood vessels can harden as (CaP) crystals, normally found in bones and teeth, build up in soft tissue as we age or as a result of illness. This can lead to complications in patients with atherosclerosis, a major cause of death in the UK whereby arteries thicken and are at risk of becoming blocked.

However a team of scientists at the BBSRC-funded Babraham Institute has discovered how CaP damages vessels, and how proteins normally found in our circulation can help prevent this process.

In the study funded by the British Heart Foundation, researchers found that small CaP crystals were being consumed by , resulting in abnormally high levels of , which can prove toxic.

They discovered that two proteins in the , fetuin-A and albumin, can slow down the uptake of CaP crystals by blood vessel cells, reducing the release of calcium ions and protecting against damage.

Dr Diane Proudfoot, who led the study, explained: "Small changes in within a cell controls many aspects of normal cell function. However, when calcium levels become excessive, the cell can die. By delaying the uptake of these crystals and reducing the release of calcium ions, proteins fetuin-A and albumin can help to keep calcium ions at a safe level."

The research, published today in the journal PLOS ONE, offers potential to develop treatments to prevent and reduce the damaging effects of CaP crystals.

Dr Proudfoot added: "Interestingly, lower levels of these proteins have been observed in patients with chronic kidney disease who can suffer a higher level of mortality due to cardiovascular disease. In the future, there is potential to use fetuin-A that has been artificially created or extracted from blood as a treatment for patients with low levels of this protein."

Professor Melanie Welham, BBSRC Executive Director for Science, said: "BBSRC-funded science helps us to explore the biological processes that underpin our health. This research provides important insights into healthy ageing and may lead to therapeutic strategies to prevent the problems associated with calcification in ageing and several diseases."

Explore further: New cause of high blood pressure and heart disease discovered

More information: Dautova Y, Kozlova D, Skepper JN, Epple M, Bootman MD, Proudfoot D (2014) Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLOS ONE.

Related Stories

New cause of high blood pressure and heart disease discovered

May 5, 2014
Why phosphate rich foods can increase blood pressure and promote vascular calcifications has been discovered by scientists at the Vetmeduni Vienna. The key is the hormone, FGF23—Fibroblast Growth Factor 23. When the level ...

New blood test detects potentially deadly calcium deposits

September 6, 2012
A new test could help identify and treat individuals at risk of developing potentially deadly calcium deposits in their tissues and blood vessels, according to a study appearing in an upcoming issue of the Journal of the ...

Cutting phosphate in diet reduces deaths, heart problems related to kidney disease

April 4, 2014
(Medical Xpress)—Millions of Americans suffer from chronic kidney disease, a condition that rarely causes symptoms until its later stages. But long before kidneys fail and dialysis becomes a way of life, the body experiences ...

Manipulating calcium accumulation in blood vessels may provide a new way to treat heart disease

April 9, 2013
Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease. It is caused by calcium accumulation in the blood vessels, which leads to arteries becoming narrow and stiff, obstructing blood flow and ...

Novel marker and possible therapeutic target for cardiovascular calcification identified

March 13, 2014
Cardiovascular calcification (deposits of minerals in heart valves and blood vessels) is a primary contributor to heart disease, the leading cause of death among both men and women in the United States according the Centers ...

Recommended for you

Study finds walnuts may promote health by changing gut bacteria

July 28, 2017
Research led by Lauri Byerley, PhD, RD, Research Associate Professor of Physiology at LSU Health New Orleans School of Medicine, has found that walnuts in the diet change the makeup of bacteria in the gut, which suggests ...

Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity

July 28, 2017
A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose ...

Manipulating a type of brain cell gets weight loss results in mice

July 28, 2017
A new study has found something remarkable: the activation of a particular type of immune cell in the brain can, on its own, lead to obesity in mice. This striking result provides the strongest demonstration yet that brain ...

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.